Investment
Features
FeesSafety
Academy
More
Pluang+

Beam Therapeutics faces investigation over clinical trial data disclosure, shares drop nearly 10%.

Market News
01 Oct 2026
PRNewsWire
View Source
Bearish
Beam Therapeutics faces investigation over clinical trial data disclosure, shares drop nearly 10%.

Pomerantz LLP is investigating Beam Therapeutics for potential securities fraud related to its September 8, 2026 press release on Phase 1/2 trial data for BEAM-302, a treatment for alpha-1 antitrypsin deficiency. The company reported that the treatment was generally safe but noted transient liver enzyme elevations, which caused Beam's stock to fall 9.54% that day. The investigation will determine if Beam or its executives engaged in unlawful practices by how they disclosed this information. This legal scrutiny could impact investor confidence and the company's stock performance going forward.

Beam Therapeutics is under investigation for potential securities fraud. For readers following the health sector, here is Pluang's market snapshot as of Oct 01, 2026 20:52 WIB: out of 100 priced health-sector US stocks, 30 rose and 67 fell. Notable movers include CTXR at USD 0.55 with a 3.58% gain and HIMS at USD 29.00 with a 2.65% loss in one day.

More News

Wells Fargo stock target raised to $95 on strong Q3 earnings forecast and Fed regulatory easing

Wells Fargo stock target raised to $95 on strong Q3 earnings forecast and Fed regulatory easing

An analyst at Truist Financial raised Wells Fargo's price target to $95, suggesting a 20.74% upside from its current price. This optimism is driven by expected strong third-quarter earnings of $1.85 per share and $22.34 billion in revenue, surpassing...

Analyst Insights
Bullish
2 hours ago
Oklo advances carbon-free energy with new reactors and $1.68B nuclear fuel recycling plan

Oklo advances carbon-free energy with new reactors and $1.68B nuclear fuel recycling plan

Oklo is developing advanced fast-fission reactors to power future data centers and industrial hubs, aiming to lead in carbon-free energy. Piper Sandler reaffirmed an "Overweight" rating on the stock, reflecting confidence in Oklo's growth prospects. ...

Market News
Bullish
2 hours ago
Nike earnings expected to show decline amid 80% stock drop and cautious market sentiment

Nike earnings expected to show decline amid 80% stock drop and cautious market sentiment

Nike is set to release its quarterly earnings on October 1, 2026, with analysts forecasting an EPS of $0.44 and revenue of $11.32 billion, both down from last year. The company's stock has fallen 80% this year, hitting 13-year lows, reflecting a chal...

Company Fundamentals
Bearish
2 hours ago
Lamb Weston expects Q3 EPS of $0.59 on stable $1.65B revenue, driven by cost savings and efficiency gains.

Lamb Weston expects Q3 EPS of $0.59 on stable $1.65B revenue, driven by cost savings and efficiency gains.

Lamb Weston is set to report Q3 earnings with analysts forecasting an EPS of $0.59, down from $0.74 last year, and revenue around $1.65 billion, nearly flat compared to the prior year. The company’s "Focus to Win" strategy has generated over $100 mil...

Company Fundamentals
Neutral
3 hours ago
Trump's meme coin holders invited to gala dinner with prizes including 18K gold watches

Trump's meme coin holders invited to gala dinner with prizes including 18K gold watches

Donald Trump announced a gala dinner for the top 185 holders of his Official Trump (TRUMP) meme coin at Trump National, Washington, DC, on November 22, 2026. The event features a competition on a time-weighted leaderboard, with top prizes including 1...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App